The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISA 2022 | Unmet needs in imaging for the diagnosis of AL amyloidosis
Maximilian Steinhardt, MD, University Hospital Würzburg, Würzburg, Germany, outlines currently used imaging techniques for the diagnosis of AL amyloidosis including echocardiography and bone scintigraphy, commenting on the limitations of these approaches, and highlighting the need for novel biomarkers to detect amyloid deposits in different organs. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
